Strength
320 mg/2mL
Manufacturer
UCB, Inc.NDC
50474078284
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
BIMEKIZUMABApproval Type
Biologic (BLA)
FDA Application
BLA761151On Market Since
12/5/2024
Price Statistics
The NADAC for BIMZELX 320 MG/2 ML AUTOINJECT has been published 42 times since Dec 17, 2025, and over the history we have for it it has risen 4.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8016.0364 per ML |
|---|---|
| All-time high | $8067.9674 (May 13, 2026) |
| All-time low | $7654.6180 (Dec 17, 2025) |
| 52-week high | $8067.9674 |
| 52-week low | $7654.6180 |
| Median price | $8031.7230 |
| Average price | $8006.8260 |
| Largest weekly change | +5.4% (Jan 14, 2026) |
| Weeks tracked | 42 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the bimekizumab market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
UCB, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
bimekizumab market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BIMZELX 320 MG/2 ML AUTOINJECT?
The current National Average Drug Acquisition Cost (NADAC) for BIMZELX 320 MG/2 ML AUTOINJECT, manufactured by UCB, Inc., is $8016.0364 per ML (NDC 50474078284), effective Sep 30, 2026.
How has the price of BIMZELX 320 MG/2 ML AUTOINJECT changed over time?
Over the history we have for it, the NADAC for BIMZELX 320 MG/2 ML AUTOINJECT has risen 4.7%. It has been tracked across 42 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for BIMZELX 320 MG/2 ML AUTOINJECT?
Since Dec 17, 2025, the NADAC for BIMZELX 320 MG/2 ML AUTOINJECT has ranged from a low of $7654.6180 (Dec 17, 2025) to a high of $8067.9674 (May 13, 2026), with a median of $8031.7230 per ML.
Are there cheaper alternatives to BIMZELX 320 MG/2 ML AUTOINJECT?
No other NADAC-published product currently shares the active ingredient and strength of BIMZELX 320 MG/2 ML AUTOINJECT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BIMZELX 320 MG/2 ML AUTOINJECT?
BIMZELX 320 MG/2 ML AUTOINJECT (NDC 50474078284) is labeled by UCB, Inc., and CMS classifies it as a brand product.